Worldwide prevalence, awareness, treatment and control of hypertension

Journal of Hypertension

Volumn 22, Issue 1, 2004, Pages 21-24

  Cruickshank, J Kennedy ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AWARENESS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; DATA ANALYSIS; EDITORIAL; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; MEDICAL LITERATURE; OUTPATIENT CARE; POPULATION RESEARCH; PRIMARY PREVENTION; PRIORITY JOURNAL; SYSTEMATIC REVIEW; SYSTOLIC HYPERTENSION;

EID: 1442274639     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200401000-00004     Document Type: Editorial

References (20)

1. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension. A systematic review. J Hypertens 2004; 22:11-18.
2. Li W, Jiang X, Ma H, Yu TS, Ma L, Puente JG, et al., on behalf of the collaborating group. Awareness, treatment and control of hypertension in patients attending hospital clinics in China. J Hypertens 2003; 21: 1191-1197.
3. Reynolds K, Gu D, Muntner P, Wu X, Chen J, Huang G, et al., on behalf of the InterASIA Collaborative Group. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens 2003; 21:1273-1281.
4. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
5. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21:1983-1992.
6. The Seventh Report of the Joint National Committee of Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The VII report. JAMA 2003; 289:2560-2572.
7. Evans JG, Rose G. Hypertension. Br Med Bull 1971; 27:37-42.
8. Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, et al., on behalf of the Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21:707-16.
9. ALLHAT writing group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002; 288:2981-2997.
10. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomised trials. Lancet 2003; 362:1527-1535.
11. Whelton P, He J, Appel L, Cutler J, Havas S, Kotchen T, et al. Primary prevention of Hypertension: clinical and public health advisory from the national High Blood Pressure Education Program. JAMA 2002; 288:1882-1888.
12. Yajnik CS, Fall CHD, Coyaji KJ, Hirve SS, Rao S, Barker DJP, et al. Neonatal anthropometry: the thin-fat Indian baby. The Pune maternal nutrition study. Int J Obes 2003; 27:173-180.
13. Cruickshank JK, Mbanya JC, Wilks R, Balkau B, Forrester T, Anderson S, McFarlane-Anderson N. Hypertension in 4 African-origin populations: current 'Rule of Halves', quality of blood pressure control and attributable risk of cardiovascular disease. J Hypertens 2001; 19:41-46.
14. Miller GJ, Kirkwood BR, Beckles GLA, Alexis SD, Carson DC, Byam NTA. Adult male all-cause, cardiovascular and cerebrovascular mortality in relation to ethnic group, systolic blood pressure and blood glucose concentration in Trinidad, West Indies. Int J Epidemiol 1988; 17:62-69.
15. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ, et al., on behalf of the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360:1347-1360.
16. Multiple authors. From compliance to concordance. BMJ 2003; 327: 7419.
17. Cruickshank JK, Gosling RG, Anderson SG, Wright JS, Riste L, Dunn G. Aortic pulse wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106:2085-2090
18. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar M, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 11:99:2434-2439.
19. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241.
20. Meaume S, Benetos A, Henry O, Rudnicki A, Safar M. Aortic PWV predicts CV mortality in subjects over 70 years old. Artherioscler Thromb Vasc Biol 2001; 21:2046-2050.